SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Decreased by Chatham Capital Group Inc.

Chatham Capital Group Inc. cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,078 shares of the exchange traded fund’s stock after selling 1,300 shares during the quarter. Chatham Capital Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $457,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Avior Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares during the period. Tidemark LLC boosted its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the period. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $43,000.

SPDR S&P Biotech ETF Stock Down 0.9 %

Shares of SPDR S&P Biotech ETF stock opened at $87.06 on Friday. The stock has a market cap of $5.74 billion, a PE ratio of 11.47 and a beta of 0.93. The business has a fifty day simple moving average of $90.68 and a 200-day simple moving average of $95.52. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.